Articles

InMode Soars after Paula Abdul Is Named Their Brand Ambassador

by BodySculpt NYC Body Sculpt - Plastic Surgery
Soon after the announcement that International Pop Icon Paula Abdul had agreed to join InMode Ltd. as their brand ambassador to share her positive experience with the Company’s innovative technologies, the medical technology company’s fortunes have reversed. As reported by Bloomberg, the stocks of InMode, the global provider of inventive medical technologies, surged on August 14, 2019 after naming Paula Abdul as a brand ambassador for its alternatives to cosmetic surgery, and strong second-quarter results. The shares of Inmode rose 25% even as the broader stock market dropped. Inmode came public market only recently in a $14 IPO.

InMode: Newly-Public Skin Treatment Firm

InMode Ltd., a leading global provider of innovative, energy-based solutions offers cutting edge medical devices for minimally-invasive and non-invasive procedures that provide amazing results for the patient and the practice. InMode’s technological advancements began over two decades ago with state-of-the-art light, laser, and radiofrequency devices invented by leading doctors and scientists, who essentially launched and shaped the industry. Their technology continues that legacy to provide superior satisfaction for both the patient and the practice.

InMode Reports Second Quarter 2019 Financial Results and Pop Icon Paula Abdul as Their Brand Ambassador

As reported by Streetwise Reports, InMode Ltd that completed an IPO (Initial Public Stock Offering) just a few days ago, reported their second quarter earnings for the period ending June 30, 2019. In a separate release, InMode also announced the appointment of pop icon Paula Abdul as a brand ambassador. This attracted a lot of public attention. The company reported record revenue of $38.8 million in the second quarter of 2019, which was an increase of 55% over 2018 2nd quarter. Apart from noticeable improvements in gross margins and operating margins, the company reported their net income of $15.8 billion or $0.45 per diluted share in the second quarter of 2019, compared to $7.6 million or $0.21 per diluted share in Q2/18. Excluding the $70 million proceeds raised in InModes IPO, the company reported a total cash position of $82.8 million including cash, cash equivalents, marketable securities and deposits. The firm’s CEO and chairman Moshe Mizrahy said that they were pleased with their second quarter results that are consistent with both their report expectations and the positive trends they were continuing to see in their business.

InMode is a leading global provider of innovative medical technologies. The company develops, manufactures, and markets medical devices harnessing the power of radiofrequency technology. Their products are available across several categories for plastic surgery, dermatology, gynecology, otolaryngology, and ophthalmology. These products and solutions are designed primarily to address three energy-based treatment categories – face and body contouring, women’s health, and medical aesthetics. 

InMode’s collaboration with pop icon Paula Abdul will definitely prove beneficial to the company. An international celebrity, Paula Abdul has made her mark in the entertainment industry as an award-winning dancer and choreographer, singer, actress, television personality with six number-one singles on the Billboard Hot 100, Emmy and Grammy awards along with many other honors. She is happy to be InMode’s brand ambassador because she experienced positive results with the company’s BodyTite system for her arms, and FaceTite and Morpheus8 hand pieces for her lower face, jaw line and neck. She wants to get the word out about the excellent results InMode’s amazing technology in face and body contouring can achieve. The treatment enabled her to restore a sleeker, more youthful look without invasive surgery. 

InMode’s minimally invasive BodyTite/FaceTite technology removes fat and contracts skin under local anesthesia. The treatment does not leave any visible scarring; downtime is minimal, and the treatment is less costly than traditional surgical procedures. Results are observed immediately and you experience continued improvement up to 12 months later.

Plastic surgeon Spero Theodorou MD of bodySCULPT in NYC, who is also InMode’s Chief Medical Officer, said that Paula was an excellent candidate for InMode’s innovative technology using Radio-Frequency (RF) to provide a natural tighter appearance. She exercised regularly, was healthy but had some areas that troubled her due to past injuries and the effects of aging. InMode’s BodyTite system proved the ideal option to sculpt and remodel Paula’s arms while the FaceTite and Morpheus8 handpieces addressed her lower face, jawline and neck. 

Positive reviews and the dynamic presence of Paula Abdul could lift InMode’s shares even higher. Shakil Lakhani, President of InMode North America, said they were thrilled to announce a strong and powerful woman like Paula representing their brand. She had an ageless presence and embodied InMode’s commitment to enhance beauty and well-being. InMode’s collaboration with Paula Abdul will ensure a greater audience is aware of the benefits of InMode’s technology on a national and global level. On her part, Paula Abdul wants to bring her renewed feeling of confidence and self-assurance to others who want the same benefits.


Sponsor Ads


About BodySculpt NYC Committed   Body Sculpt - Plastic Surgery

472 connections, 6 recommendations, 1,517 honor points.
Joined APSense since, March 23rd, 2013, From New York City, United States.

Created on Sep 4th 2019 04:23. Viewed 507 times.

Comments

No comment, be the first to comment.
Please sign in before you comment.